Injection Liraglutide: Format, Delivery, and Dose Basics

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where GLP-1 delivery formats, weight-management options, and metabolic genetics are explained without hype.

Most people searching "liraglutide injection" are working out a delivery question: is there a pill, is there a shot, and what practically separates them? Liraglutide is also the unusual member of the GLP-1 family that runs on a daily rather than weekly rhythm, which makes the format question worth answering carefully. Here is the market reality, the delivery trade-offs, and where PlexusDx does and does not fit.

Pill or shot: the liraglutide format question

Liraglutide is available in the FDA-approved market in whatever format its current product label specifies. Rather than guess, check the relevant prescribing information or ask a healthcare provider for the authorized formats in effect for you. That label is the definitive source — marketing copy and third-party summaries are not.

Why liraglutide keeps a daily rhythm

Injectable GLP-1 receptor agonists are generally dosed once weekly, but liraglutide is the exception dosed once daily. That cadence difference matters for planning: a daily injectable asks for a consistent everyday routine, where weekly agonists ask you to remember a single day. Neither is inherently better — the right fit depends on how you actually live.

How oral and injectable delivery differ

The route a GLP-1 takes into your body drives much of the practical experience.

What injectable delivery offers

Injectable GLP-1 receptor agonists deliver predictable bioavailability, which is a large part of why they anchor most protocols. The medication reaches the bloodstream reliably without needing to survive digestion first.

What oral delivery requires

Oral GLP-1 receptor agonists have to survive gastric digestion. Rybelsus uses an absorption enhancer (SNAC) to get semaglutide into the system and requires strict fasting administration. Real-world adherence then depends on preference, injection tolerance, timing demands, and lifestyle. Head-to-head efficacy data between oral and injectable semaglutide in chronic weight management is limited, and oral semaglutide is labeled for type 2 diabetes, not weight management.

Reading the titration numbers

Injectable semaglutide is titrated per label from 0.25 mg weekly through higher doses (Ozempic up to 2 mg, Wegovy up to 2.4 mg). Injectable tirzepatide moves from 2.5 mg weekly up to 15 mg (Mounjaro and Zepbound). Rybelsus (oral semaglutide) starts at 3 mg daily and climbs to 7 or 14 mg. None of these figures replace your prescriber's directions.

What format choice does to cost

Oral and injectable formats are priced separately, follow different insurance coverage rules, and may qualify differently for manufacturer savings programs. The PlexusDx Weight Management Protocols publish per-protocol pricing on each product page. PlexusDx does not sell, distribute, or prescribe liraglutide or any therapeutic peptide beyond the semaglutide and tirzepatide in those protocols.

Your genes sit upstream of the format decision

Whatever GLP-1 pathway compound you eventually discuss with a provider, the underlying genetic architecture holds steady. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO, GLP1R, and MC4R that shape appetite regulation, baseline GLP-1 signaling, and energy balance. It never predicts response to liraglutide or any drug; it offers trait context, not a forecast. See related delivery reads on injectable semaglutide and injectable tirzepatide.

This article is educational. Within the GLP-1 category, PlexusDx works only with semaglutide and tirzepatide through its Weight Management Protocols; it does not sell, prescribe, or recommend dulaglutide, liraglutide, cagrilintide, or retatrutide. Retatrutide is investigational and is not sold by PlexusDx. The Precision Peptide Genetic Test never predicts response to a specific medication. Speak with a qualified healthcare provider before starting any peptide protocol.

What a daily cadence means in practice

Because liraglutide sits on the daily side of the class rather than the weekly side, the everyday rhythm becomes part of the decision. A daily injectable rewards a steady routine, while a weekly agonist asks you to remember a single recurring day. Real-world adherence, as with any of these medications, depends on personal preference, comfort with injections, the ability to meet timing requirements, and how the schedule fits your life. Neither cadence is inherently superior; the better fit is simply the one you are most likely to keep up with consistently. Your prescribing provider weighs that alongside the FDA-approved indication on your prescription, your history, and other medications you take before settling on any format or schedule.

Frequently Asked Questions

Is liraglutide a daily or weekly injection?

Among GLP-1 receptor agonists, liraglutide is the once-daily exception rather than the once-weekly norm. That everyday cadence is worth factoring into your routine. For the exact authorized format and schedule that apply to you, rely on the current product label and your prescriber rather than general summaries.

Is there an oral version of liraglutide?

As of April 2026, Rybelsus (oral semaglutide) is the only FDA-approved oral GLP-1 receptor agonist, and it is labeled for type 2 diabetes, not weight management. There is no FDA-approved oral tirzepatide. PlexusDx offers separate oral semaglutide and tirzepatide protocols through its Weight Management Protocols.

How do injectable and oral GLP-1 delivery compare?

Injectable delivery gives predictable bioavailability without surviving digestion first. Oral semaglutide relies on an absorption enhancer and strict fasting rules. Head-to-head weight-management efficacy data between the two is limited, and oral semaglutide is approved for type 2 diabetes rather than chronic weight management, so format choice is individual.

Does the genetic test say which format suits me?

No. The Precision Peptide Genetic Test does not predict response to any compound or delivery format. It reads pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that relate to baseline GLP-1 and energy-balance biology — upstream context that applies whether a compound is taken orally or by injection, not a recommendation.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.